No link found between patient genetics and response to anti-IL17 therapy
A new study looked at the effect of patient genetics on their response to secukinumab, an anti-IL17 therapy commonly used to treat inflammatory conditions including arthritis and psoriasis. No link was found between a patient's ...
Sep 6, 2023
0
20